ニューヨークにおける大腸癌の臨床試験
ニューヨーク内の拠点で、大腸癌に関する100件の研究が参加者を募集しています。
ニューヨーク内の都市
- New York City78件の研究
- Queens31件の研究
- Greenburgh11件の研究
- The Bronx9件の研究
- Staten Island8件の研究
- New Rochelle6件の研究
- Buffalo6件の研究
- Shirley6件の研究
- Syracuse5件の研究
- Brooklyn4件の研究
- Rochester3件の研究
- Yonkers3件の研究
公式研究テキスト（英語）
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07454642Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
- Kings County Hopsital Center, Brooklyn
- Queens Cancer Center of Queens Hospital, Jamaica
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/10/05更新 · NCT04751435A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Perlmutter Cancer Center at NYU Langone Health (contact for more locations), New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07659795A Study of Mental Health Care in People With Cancer
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中
65歳以上 · 全性別 · 2026/10/05更新 · NCT06037954A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Northwell Health Center for Advanced Medicine. /ID# 279590, Lake Success
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07525206A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New York Long Island LLC, Lake Success
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- New York Harbor Health Care System - Dept of Veterans Affairs, New York
被験者募集中
65歳〜82歳 · 全性別 · 2026/10/02更新 · NCT05612347Family Communications After Genetic Testing
- Glens Falls Hospital, Glens Falls
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- Memorial Sloan Kettering Commack, Commack
- The New York Hospital Medical Center of Queens, Flushing
- 他15件
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #60, New York
- Exelixis Clinical Site #6, New York
- Exelixis Clinical Site #76, Syracuse
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Memorial Sloan-Kettering Cancer Center, New York
- New York Cancer & Blood Specialists, Shirley
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center-Weiler Hospital, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05803382Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- NYOH Albany Cancer Center, Albany
- Hematology-Oncology Associates of Central New York, PC, Auburn
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
- 他12件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0327), Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0324), New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06428409A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Perlmutter Cancer Center at NYU Long Island, Mineola
- NYU Langone Medical Center NYU Hematology Associates, New York
- New York Cancer and Blood Specialists, Shirley
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- GSK Investigational Site, New Hyde Park
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07277270Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- NYU Langone Medical Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- NYU Langone Long Island Clinical Research Associates, New York
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05379595Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, New York
- Research Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06218914A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Perlmutter Cancer Center at NYU Long Island, Mineola
- Mount Sinai, New York
- Mount Sinai West, New York
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, East White Plains
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT05863195A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, Mineola
- New York Cancer and Blood Specialists, Shirley
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Commack
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07227636Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Northwell Health / RJ Zuckerberg Cancer Center, Lake Success
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- NYU Langone Health Perlmutter Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960Tislelizumab in People With Colorectal Cancer
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06529523Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07349537Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Ny Cancer and Blood Specialists, Shirley
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park
- New York Cancer and Blood Specialists-Central Park Hematology & Oncology, New York
- New York Cancer & Blood Specialists, Port Jefferson Station
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/11更新 · NCT04929223A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- White Plains Hospital Medical and Wellness PRIME, White Plains
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07549412Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Mineola
- Clinical Study Site, New York
- Clinical Study Site, Rochester
- 他3件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。